LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.26 | 27.76 | 2495 | 6465 | 0.3859 | 0.7719 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.26 | 27.76 | 3013 | 6465 | 0.4660 | 0.8149 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.26 | 27.76 | 3031 | 6465 | 0.4688 | 0.8163 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.97 | 27.76 | 2467 | 6656 | 0.3706 | 0.7640 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.97 | 27.76 | 2501 | 6656 | 0.3757 | 0.7671 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.97 | 27.76 | 388 | 6656 | 0.0583 | 0.3960 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.97 | 27.76 | 2626 | 6656 | 0.3945 | 0.7780 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.97 | 27.76 | 3128 | 6656 | 0.4699 | 0.8178 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.97 | 27.76 | 3141 | 6656 | 0.4719 | 0.8187 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 66.67 | 27.76 | 2601 | 6695 | 0.3885 | 0.7748 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 66.67 | 27.76 | 2638 | 6695 | 0.3940 | 0.7779 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 66.67 | 27.76 | 436 | 6695 | 0.0651 | 0.4162 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 66.67 | 27.76 | 2819 | 6695 | 0.4210 | 0.7929 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 66.67 | 27.76 | 3356 | 6695 | 0.5012 | 0.8329 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 66.67 | 27.76 | 3373 | 6695 | 0.5038 | 0.8340 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 68.37 | 27.76 | 2618 | 6879 | 0.3806 | 0.7712 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 68.37 | 27.76 | 2646 | 6879 | 0.3846 | 0.7736 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 68.37 | 27.76 | 439 | 6879 | 0.0638 | 0.4150 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 68.37 | 27.76 | 2930 | 6879 | 0.4259 | 0.7965 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 68.37 | 27.76 | 3385 | 6879 | 0.4921 | 0.8294 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 68.37 | 27.76 | 3482 | 6879 | 0.5062 | 0.8359 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.08 | 27.76 | 2714 | 6849 | 0.3962 | 0.7801 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.08 | 27.76 | 2744 | 6849 | 0.4006 | 0.7825 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.08 | 27.76 | 486 | 6849 | 0.0710 | 0.4337 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.08 | 27.76 | 3063 | 6849 | 0.4472 | 0.8074 | MN20160318_Q01 | F14 |